C/EBPε, a member of the CCAAT/enhancer binding protein family, is a transcription factor important in neutrophil differentiation. We have determined that it is phosphorylated on multiple serine and threonine residues, and can be a target for phosphorylation by a number of kinases. We identified a threonine at amino acid 75, part of a consensus MAP kinase site within the transactivation domain of C/EBPε, as being phosphorylated only by p38 MAP kinase. Phosphorylation of this residue resulted in enhanced transcriptional activity on a myeloid-specific promoter in in vitro transient transfection reporter assays. We also determined that phosphorylation at Thr75 yielded a protein that was more effective at binding it's cognate DNA sequence compared to the wild type non-phosphorylated C/EBPε. Stable expression of C/EBPεT75A in IL-3-dependent 32Dcl3 did not result in the up-regulation of expression of secondary granule genes compared to wild type C/EBPε or C/EBPεT75D. Therefore we suggest that C/EBPε is a target for p38 MAP kinase activity.
Introduction
Gene expression in response to external stimuli is regulated by the activity of transcription factors. The activity of these transcription factors is tightly regulated by a variety of post-translational modifications, including acetylation and phosphorylation.
Phosphorylation is one of the major, and most extensively studied, mechanisms for modulating transcription factor activity.
Many studies on transcription factors have demonstrated them to be modular proteins with separate domains for DNA binding and either transactivation or repression.
C/EBPε is a member of the CCAAT/enhancer binding protein family of transcription factors, which we previously demonstrated had both transactivation and repression domains. 1, 2 The CCAAT/enhancer binding protein family also includes C/EBPα, C/EBPβ, C/EBPδ and CHOP/GADD153. [3] [4] [5] [6] The C/EBP family of transcription factors are phosphoproteins and the phosphorylation of these proteins has been shown to affect their function. C/EBPβ is the most extensively studied member of this transcription factor family with respect to phosphorylation.
C/EBPβ is phosphorylated by a number of protein kinases including protein kinase A (PKA), protein kinase C (PKC), glycogen synthase kinase 3 (GSK3), mitogenactivated protein kinases (MAPKs), RSK and calcium-calmodulin kinase II (CaMKII).
Phosphorylation affects a number of the functions of C/EBPβ, including inhibition of DNA binding, intracellular re-localization to the nucleus, increased transcriptional activity and inhibition of apoptosis.
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In contrast to C/EBPα and C/EBPβ, phosphorylation in the DNA binding domain of C/EBPδ by casein kinase 2 actually increased DNA binding. 15 C/EBPδ can also be phosphorylated by MAPKs resulting in the translocation of this protein to the nucleus. 16 MAP kinases can phosphorylate another member of the C/EBP family, CHOP/GADD153. In this case CHOP/GADD153 showed increased transcriptional activity.
Members of the C/EBP family are expressed in myeloid cells but appear to play different roles in differentiating and mature cells. C/EBPε is expressed almost exclusively in myeloid cells with its expression reaching a peak in mature neutrophils and macrophages. 17, 18 Both C/EBPβ and C/EBPδ are regulators of cytokine gene expression in macrophages, whereas C/EBPα is critical for granulocytic differentiation. [19] [20] [21] As well as being expressed in hematopoietic cells, C/EBPα, C/EBPβ and CHOP/GADD153 also play an important role in adipocyte differentiation. p38 MAP kinase can phosphorylate both C/EBPβ and CHOP/GADD153 with opposing effects on adipocyte differentiation.
Phosphorylation of C/EBPβ by p38 MAPK is essential for adipocyte differentiation, whereas phosphorylation of CHOP/GADD153 by p38 MAPK results in an inhibition of adipocyte differentiation. 22, 23 Thus phosphorylation of transcription factors involved in the same pathway by the same kinase allows for tight regulation of that differentiation pathway. Also phosphorylation of a specific transcription factor by a specific kinase may be required for the differentiation of a specific cell type.
For personal use only. on . by guest www.bloodjournal.org From 5 Therefore, we studied C/EBPε in order to determine the sites of phosphorylation, the kinases responsible for these phosphorylations and the effect, if any, on C/EBPε function. This study demonstrates that C/EBPε is phosphorylated on multiple serine and threonine residues, by a number of different kinases. We identified a phosphoacceptor site within the N-terminal transactivation domain of C/EBPε that was specifically phosphorylated by p38 MAP kinase. Phosphorylation of this residue results in increased transactivation on a myeloid-specific promoter accompanied by increased binding of C/EBPε to its cognate DNA sequence. C/EBPε phosphorylated on this residue was also able to up-regulate the expression of myeloid-specific secondary granule genes in vivo.
For
Materials and methods

CMV-C/EBPε constructs
Single point mutations were introduced into wild type C/EBPε by PCR using overlapping mutated oligonucleotides, followed by a second round of PCR using external primers containing appropriate restriction sites. 24 The resulting PCR products were digested with the appropriate restriction enzymes and ligated into a CMV-expression vector, pCMV-SPORT (Invitrogen). The presence of these point mutations within C/EBPε was confirmed by sequencing.
Transient transfections and reporter assays
Transient transfection assays were performed in Jurkat cells using Lipofectin (Invitrogen) with 3 µg promoter-luciferase reporter and 0.3 µg of the C/EBPε expression vectors, wild type or mutants, as previously described. 25 The internal control for transfection efficiency was 1 µg pCMV-β-galactosidase. At 24 hours post-transfection, the Jurkat cells were activated with TPA (2 ng/ml) and the calcium ionophore A23187 (250 ng/ml) for 16
hours. After this time the transfections were harvested and the luciferase and β-galactosidase activities were measured according to the manufacturer's instructions (Promega). In some assays the following inhibitors (Calbiochem) were added for 60 minutes prior to activation: SB203580 (5 µM) and SB202190 (2.5 µM) for inhibition of p38 MAP kinase; H-89 (50nM), an inhibitor of PKA; and KN-62 (1.5 µM), an inhibitor of CaMKII. 
In vitro kinase assays
Equal amounts (5 µg) of the GST-C/EBPε fusion proteins were incubated with the activated kinase (1-10 U) in kinase-specific reaction buffer containing 10 µCi γ-32 P-ATP.
The kinases used for these assays were PKA (Roche), PKC (Roche), ERK2 (UBI), p38α 
2D phosphoamino acid analysis
The in vitro kinased GST-C/EBPε fusion proteins were eluted overnight from the dried polyacrylamide gel in buffer P (25 mM N-ethylmorpholine pH 7.7) and then precipitated. were detected by ninhydrin staining of the TLC plate and the 32 P-labeled phosphoamino acids were visualized by autoradiography.
Nuclear protein analysis
Jurkat cells were transfected with 5 µg of the CMV-C/EBPε expression plasmids, wild type and mutated, as described above. The empty vector pCMV-SPORT was used as the negative control for these experiments. Nuclear proteins were prepared as previously described. 25 The nuclear extracts were initially separated by SDS-PAGE and analyzed by Western immunoblot to confirm expression of the various C/EBPε proteins. DNA binding by the C/EBPε proteins was determined by EMSA using double-stranded oligonucleotides containing the C/EBP consensus site and adjacent sequences of the mim promoter. 25 A standard reaction for the EMSA contained 2.5 ng 32 P-labeled oligonucleotide, 10 µg Jurkat nuclear extract expressing either wild type or mutated C/EBPε, 1.5 µg poly dIdC and 4.5 µg bovine serum albumin in a 20 µl volume.
Competing cold oligonucleotides at 100-fold molar excess or antibodies (1 µg) were added where indicated. Electrophoresis was performed on a 4% polyacrylamide gel at 34 mA for 2-3 hours. The gel was dried, and the results visualized by autoradiography. In order to demonstrate changes in 32Dcl3 cells occurring with the stable expression of C/EBPε proteins total RNA was isolated from exponentially growing 32D-C/EBPε-expressing cells using Trizol according to the manufacturer's instructions (Invitrogen). 10 µg total RNA was separated on formaldehyde-agarose gels. The RNA was Northern blotted onto Hybond+ membrane with 10X SSC, baked and hybridized sequentially with 32 P-α-dCTP-labeled probes for the secondary granule genes NGAL and B9 and a probe for 18S as the control for equal sample loading of the gel. Results were visualized by autoradiography.
Transduction of C/EBPε
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Results
C/EBPε can be phosphorylated in vitro by multiple kinases
Since other C/EBP family members have been shown to be the target of a number of kinases, we analyzed the protein sequence of C/EBPε and identified a number of potential phosphoacceptor sites. We then carried out a series of in vitro kinase assays to confirm that C/EBPε was a substrate for these kinases as suggested by the protein Previously we had determined, by in vivo labeling, that C/EBPε was phosphorylated on multiple serine and threonine residues but not on tyrosine residues 2 .
Furthermore, in vivo labeling with a series of C/EBPε deletion mutants previously described, 38 demonstrated that only threonine residues were phosphorylated within the Nterminal transactivation domain of C/EBPε (data not shown). Potentially both serine and threonine residues in C/EBPε could be phosphorylated by PKA, ERK2 and p38α MAP kinase. Therefore we performed 2D phosphoamino acid analysis on the in vitro kinased GST-C/EBPε to determine the identity of the residues phosphorylated by each of these three kinases. This experiment demonstrated that both ERK2 and PKA kinase activity Therefore, these results suggest that Thr75 within the N-terminal transactivation domain of C/EBPε is a target for the p38 MAP kinase signaling pathway.
Mutation of Thr75 alters the capacity of C/EBPε to activate gene transcription
Although Thr75 appears to be a target for p38 MAP kinase in vitro, this does not necessarily mean that phosphorylation or lack of it at this site will affect the function of C/EBPε in vivo. Studies of other C/EBP family members showed that some residues can be phosphorylated in vitro but not in vivo and vice versa. 9,11 Therefore we wanted to determine whether mutation of this amino acid could affect the ability of C/EBPε to
transcriptionally activate a myeloid-specific promoter. Thus two C/EBPε mutants, C/EBPεT75A (non-phosphorylated) and C/EBPεT75D (threonine to aspartate to mimic a phosphorylation event), were generated and subcloned into a CMV-driven expression vector. These two constructs were then used in transient transfection assays with a myeloid-specific promoter-luciferase construct and compared to the wild type C/EBPε activity on this promoter. The Jurkat cell line was used for these transient reporter assays since it does not express detectable levels of endogenous C/EBPε.
In the transient reporter assays, the wild type C/EBPε activated the promoterluciferase reporter construct by 7.5-fold, while the C/EBPεT75A mutant activated the promoter only 3.7-fold ( Figure 3 ). In contrast, C/EBPεT75D was even more effective at activating the promoter, giving a 10.5-fold increase in activity on the promoter-luciferase reporter ( Figure 3) . These results suggest that phosphorylation (or lack of it) at Thr75 does have an effect on the ability of C/EBPε to activate gene transcription.
Furthermore when a series of protein kinase inhibitors was used in these transient reporter assays, only inhibitors of p38 MAP kinase inhibited the ability of wild type C/EBPε to transactivate the promoter-luciferase reporter (Figure 3) .
Mutation of minimal MAP kinase sites can also affect C/EBPε function
We were also interested to examine the effect of phosphorylation on the three minimal MAP kinase sites. However, only two are conserved between human and murine C/EBPε. These are Ser181 and Ser188, which are located in the C-terminal region of the repression domain of C/EBPε. Therefore we generated mutations of these two serine residues converting each to either alanine or aspartate as we had done previously for Thr75. We then used these new constructs in transient transfection reporter assays using the mim promoter-luciferase construct.
For these two sites, C/EBPεS181A and C/EBPεS188D were able to activate the mim promoter-luciferase construct in these assays but were not as effective as the wild type C/EBPε (Figure 3) . However, the other mutations C/EBPεS181D and C/EBPεS188A did not significantly activate the mim promoter (Figure 3 ).
Phosphorylation of other C/EBP family members has been shown to affect intracellular localization. 8, 27 Therefore, the expression of these mutant C/EBPε proteins was examined ( Figure 4 ). Western immunoblot analysis determined that all C/EBPε proteins were expressed at similar levels, but the C/EBPεS188A mutant protein was the only one not localized to the nucleus (Figure 4 ). Subsequent analysis demonstrated that this mutant C/EBPε protein appeared to now be localized to the cytoplasm, hence its lack of activity in the reporter assays ( Figure 3 ).
Phosphorylation alters DNA binding affinity of C/EBPε
Since all but one of our mutant C/EBPε proteins are correctly localized to the nucleus and expressed at similar levels, we were interested to examine their ability to bind their cognate DNA sequence. Therefore gel shift analysis was performed using nuclear extracts from Jurkat cells transfected with either wild type or mutant forms of C/EBPε and an oligonucleotide from the mim promoter containing a cognate C/EBPε binding site and surrounding sequences.
The gel shift analysis demonstrated that wild type C/EBPε, C/EBPεT75A, C/EBPεT75D, C/EBPεS181A, C/EBPεS181D and C/EBPεS188D all bound the For personal use only. on April 14, 2017. by guest www.bloodjournal.org From oligonucleotide containing the C/EBPε binding site from the mim promoter ( Figure 5A ).
In these gel shift experiments, the DNA-protein complex could be competed away by the inclusion of the same unlabeled oligonucleotide, and it could be supershifted with a C/EBPε-specific antibody ( Figure 5A ).
Although all C/EBPε proteins bound to the cognate DNA sequence, there appeared to be an increase DNA binding by the nuclear extract containing C/EBPεT75D compared to the wild type C/EBPε ( Figure 5A ). Therefore we wanted to determine whether there was a real change in DNA binding by the C/EBPεT75D mutant protein.
Therefore, further EMSA were carried out using a constant amount of the C/EBPε proteins and increasing dilutions of the oligonucleotide ( Figure 5B ). Wild type C/EBPε demonstrated good binding for its cognate DNA sequence at 10 nM of oligonucleotide ( Figure 5B ). However, this DNA-protein complex was very weak even when the oligonucleotide was diluted to only 5 nM ( Figure 5B ). In contrast, binding of C/EBPεT75D was strong even when the oligonucleotide had been diluted to 0.25 nM ( Figure 5B ). Scatchard analysis determined that the DNA binding affinity for wild type C/EBPε is 7.69 nmol/L. This value is about the same as the DNA binding affinity of C/EBPε previously determined by our group. 25 In contrast, the DNA binding affinity of C/EBPεT75D is 0.48 nmol/L. This demonstrates that C/EBPεT75D binds its cognate DNA with 16-fold more affinity than wild type C/EBPε. Therefore, phosphorylation of Thr75 dramatically increases the DNA binding ability of the C/EBPε protein.
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In vivo effects of C/EBPεT75D expression
The previous experiments are all in vitro analyses for effects on C/EBPε function after phosphorylation. Therefore we were interested in investigating the biological effects of expression of phosphorylation mutants of C/EBPε in a cell line capable of granulocytic differentiation. The 32Dcl3 cells were chosen for stable transfection. Following retroviral infection of the 32Dcl3 cells, a series of clones were isolated for each C/EBPε protein.
Protein lysates were made from each clone and analyzed by Western immunoblotting with an antibody specific for C/EBPε. Clones were selected which expressed similar levels of the C/EBPε proteins ( Figure 6A ).
The C/EBPε knock-out mice are deficient in secondary granule gene expression. 27 Therefore we were interested to examine whether these stably transfected 32Dcl3 cells were expressing secondary granule genes, even when not undergoing differentiation. 
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Analysis of 32Dcl3 cells expressing either C/EBPεS181D or C/EBPεS188D demonstrated that neither of these mutant proteins could up-regulate secondary granule gene expression. This lack of activity correlated with their level of activity in the luciferase-reporter assays (Figure 3 
Discussion
The activity of transcription factors is regulated in a rapid and reversible manner by specific phosphorylations. This study demonstrates that C/EBPε is phosphorylated in vivo on multiple serine and threonine residues, that it is a substrate in vitro for the protein kinases PKA, ERK2 and p38 MAP kinase. The combination of these in vivo and in vitro analyses suggested that p38 MAP kinase was the protein kinase responsible for the Although we focused mainly on Thr75, we also assessed the effect of other phosphorylations by MAP kinases on C/EBPε function. The effect of phosphorylation on two serine residues within the repression domain of C/EBPε was studied. For these, the effects were mixed and not as dramatic as for Thr75. De-phosphorylation of Ser188 appeared to relocalize the C/EBPε protein to the cytoplasm. Whereas phosphorylation of Ser181 gave a C/EBPε protein that could bind DNA as well as wild type C/EBPε but was inactive on a myeloid-specific promoter.
We analyzed individually these three MAP kinase sites, Thr75, Ser181 and Ser188. However, in vivo distinct protein kinases and phosphatases exist which orchestrate the responses of a transcription factor to a variety of external stimuli. These transcription factors frequently contain both stimulatory and inhibitory phosphorylation sites which allows for a dynamic process resulting in the fine tuning of the transactivation potential. Thus phosphorylation is a mechanism which provides for tight regulation of the activity of a transcription factor rather than being a simple switch for turning both on and off the activity of a transcription factor.
With respect to C/EBPε, we suggest that Thr75 is frequently phosphorylated under normal growth conditions, but that this is elevated upon other external stimuli. In this case, a stoichiometric shift occurs towards phosphoThr75 in any given population of C/EBPε knock-out mice it was found that the cells of the granulocytic lineage have an impaired ability to migrate, a reduced capacity to produce superoxide and do not express secondary granule proteins. 27 The p38 MAP kinase is involved in mediating intracellular signals resulting in superoxide production and cell migration. In human neutrophils, inhibition of p38 MAP kinase results in decreased superoxide anion production, reduction in adhesion and chemotaxis in response to fMLP and inhibition of release of IL-8 in response to LPS. 31, 32 Therefore, p38 MAP kinase appears to be important for neutrophil function.
The defects observed for the C/EBPε knock-out mice are also observed in a number of diseases as well as other mouse knock-out models. These include humans with specific granule disease (SGD) for which mutations of C/EBPε have been identified, and chronic granulomatous disease (CGD), as well as Rac2 knock-out mice. [33] [34] [35] [36] More recently a human neutrophil immunodeficiency syndrome has been identified resulting from a mutation of Rac2. 37 Rac2 is a member of the Rho family of GTPases which is highly expressed in myeloid cells and is a regulator of the NADPH-oxidase complex. Therefore, the phenotype observed in C/EBPε knock-out mice represents a defect intrinsic to neutrophil function.
Neutrophils are rapidly activated and short-lived. Therefore, C/EBPε has to be rapidly activated in response to an external stimulus. We hypothesize that C/EBPε may be phosphorylated in non-stimulated neutrophils and bound to its cognate DNA sequence.
Activation of p38 MAP kinase signaling pathways could then result in the rapid phosphorylation of the threonine reside at amino acid 75, such that C/EBPε more efficiently binds DNA and can rapidly activate the transcription of genes necessary for neutrophil function. Northern blot analysis with probes for the secondary granule genes NGAL and B9. A probe specific for 18S was used as the loading control.
